It Is Too Early for Pharma Investors to Cheer Opioid Verdict

Hold the celebration: The opioid litigation cloud hanging over drug stocks won’t clear up soon.

An Oklahoma judge ruled Monday that Johnson & Johnson is liable for fueling the opioid crisis and must pay $572 million. At first glance, that seems like a win for shareholders. The state’s attorneys had asked for as much as $17 billion in damages. Purdue Pharma and Teva Pharmaceutical Industries, which opted to settle Oklahoma’s claims instead of going to trial, paid $270 million and $85 million to resolve their cases, respectively.

So this opens up grounds to sue for the victims and families

So basically a drug cartel gets a giant verdict and we’re writing about how the shareholders are affected? Not all the people who they intentionally hooked on hard drugs and fed into the disease of addiction, many of whom are now dead the others lives destroyed

When are the victims of mass shootings going to sue because of the part psychotropic drugs play. They already ruled prozac was responsible for a mass shooting in Canada. The more you know...

Home town verdict Appeal will be another issue

Between 2015-2018, 18 million opioid prescriptions were written in Oklahoma. A Republican state with a population of 3.9 million people. Sad. TrumpCountry

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Shares of pharma companies soar after Johnson & Johnson sees smaller-than-expected opioid fineShares of major pharmaceutical companies surged in after-hours trading Monday following a smaller-than-expected fine for Johnson & Johnson. Is UP💰💰💰 Such a shame. So many lives have been lost or destroyed because of these products. The fine is way too small. 👇👇👇👇👇👇👇👇👇👇
Source: CNBC - 🏆 12. / 72 Read more »